Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

vertex pharmaceuticals (ch) gmbh - tezacaftorum, ivacaftorum - filmtabletten - filmtablette morgendosis (tezacaftorum 100 mg / ivacaftorum 150 mg): tezacaftorum 100 mg, ivacaftorum 150 mg, hypromellosi acetas succinas, natrii laurilsulfas, hypromellosum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, talcum, e 171, e 172 (flavum) pro compresso obducto corresp. natrium 2.74 mg. filmtablette abenddosis (ivacaftorum 150 mg): ivacaftorum 150 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 167.2 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 132, cera carnauba, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 1.82 mg. - behandlung zystischer fibrose - synthetika

Europäische Union - Deutsch - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - mukoviszidose - andere produkte für die atemwege - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

vertex pharmaceuticals (ch) gmbh - tezacaftorum, ivacaftorum - filmtabletten - filmtablette morgendosis (tezacaftorum 50 mg / ivacaftorum 75 mg): tezacaftorum 50 mg, ivacaftorum 75 mg, hypromellosi acetas succinas, natrii laurilsulfas, hypromellosum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, talcum, e 171 pro compresso obducto corresp. natrium 1.37 mg. filmtablette abenddosis (ivacaftorum 75 mg): ivacaftorum 75 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, lactosum monohydricum 83.6 mg, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 132, cera carnauba, drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 0.9 mg. - behandlung zystischer fibrose - synthetika